Expert opinion on therapeutic patents
Coactivator-associated arginine methyltransferase 1 (CARM1) inhibitors: a patenting perspective (2018-present).
Monica Viviano, Alessandra Cipriano, Alessandra Feoli, Ciro Milite, Sabrina Castellano, Gianluca Sbardella
Published: 202510.1080/13543776.2025.2600946
Abstract
INTRODUCTION: CARM1 (Coactivator-associated arginine methyltransferase 1), also known as PRMT4 (Protein Arginine Methyltransferase 4), is a type I PRMT that regulates gene expression by methylating both histone and non-histone substrates. Its overexp…
Preview only. Read the full abstract at the source